Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
Department of Neurology, Suiseikai Kajikawa Hospital, Hiroshima, Japan.
PLoS One. 2020 Oct 28;15(10):e0241205. doi: 10.1371/journal.pone.0241205. eCollection 2020.
To assess the influence of periodontal disease on cerebral hemorrhage and its clinical course, we examined the association of the serum IgG titer of periodontal pathogens with hemorrhage growth and 3-month outcome. We consecutively enrolled 115 patients with acute cerebral hemorrhage (44 females, aged 71.3 ± 13.1 years) and used ELISA to evaluate the serum IgG titers of 9 periodontal pathogens: Porphyromonas gingivalis, Aggregatibacter (A.) actinomycetemcomitans, Prevotella intermedia, Prevotella nigrescens, Fusobacterium (F.) nucleatum, Treponema denticola, Tannerella forsythensis, Campylobacter rectus, and Eikenella corrodens. Significant hematoma growth was defined as an increase in the volume of >33% or an absolute increase in the volume of >12.5 mL. A poor outcome was defined as a 3 or higher on the modified Rankin Scale. We observed hemorrhage growth in 13 patients (11.3%). Multivariate analysis revealed that increased IgG titers of A. actinomycetemcomitans independently predicted the elevated hemorrhage growth (odds ratio 5.26, 95% confidence interval 1.52-18.25, p = 0.01). Notably, augmented IgG titers of F. nucleatum but not A. actinomycetemcomitans led to a poorer 3-month outcome (odds ratio 7.86, 95% confidence interval 1.08-57.08, p = 0.04). Thus, we demonstrate that elevated serum IgG titers of A. actinomycetemcomitans are an independent factor for predicting cerebral hemorrhage growth and that high serum IgG titers of F. nucleatum may predict a poor outcome in patients with this disease. Together, these novel data reveal how systemic periodontal pathogens may affect stroke patients, and, should, therefore, be taken into consideration in the management and treatment of these individuals.
为了评估牙周病对脑出血及其临床过程的影响,我们研究了牙周病病原体血清 IgG 滴度与出血增长和 3 个月结局的相关性。我们连续纳入 115 例急性脑出血患者(44 名女性,年龄 71.3 ± 13.1 岁),并使用 ELISA 评估 9 种牙周病病原体的血清 IgG 滴度:牙龈卟啉单胞菌、伴放线放线杆菌、中间普氏菌、黑色普氏菌、福赛斯坦纳菌、牙髓卟啉单胞菌、 Tannerella forsythensis、直肠弯曲杆菌和侵蚀艾肯菌。显著血肿增长定义为体积增加>33%或绝对增加>12.5ml。预后不良定义为改良 Rankin 量表评分为 3 或更高。我们观察到 13 名患者(11.3%)发生血肿增长。多变量分析显示,伴放线放线杆菌 IgG 滴度增加独立预测出血增长(比值比 5.26,95%置信区间 1.52-18.25,p = 0.01)。值得注意的是,核梭杆菌 IgG 滴度升高而非伴放线放线杆菌 IgG 滴度升高与 3 个月预后不良相关(比值比 7.86,95%置信区间 1.08-57.08,p = 0.04)。因此,我们证明了伴放线放线杆菌血清 IgG 滴度升高是预测脑出血增长的独立因素,而核梭杆菌血清 IgG 滴度升高可能预示此类疾病患者预后不良。这些新数据揭示了全身牙周病原体如何影响脑卒中患者,因此,在这些患者的管理和治疗中应考虑到这些因素。